MedTrace Logo

Trends in Live Birth Rates Attributable to Assisted Reproductive Technology in British Columbia

NCT04373239 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-12-13

No results posted yet for this study

Summary

Investigators will examine trends in ART use in BC specifically. The use of ART has drastically changed the management of infertility, with worldwide estimates exceeding 1.8 million ART cycles in 2010 alone. Moreover, an excess of six million children have been conceived using ART. Although various countries have published their live birth rates associated with common ART treatment strategies, British Columbia has yet report on its rates. With varying differences in ART practices, whether clinical or laboratory, it is expected live birth rates due to ART to vary depending on region analyzed. Analyzing the live birth rate in BC would not only allow for a benchmark for assessing future improvement, and trends in infertility diagnosis and management, but also allow for comparison to other provinces and countries. The aim of this part of the study is to describe ART cycle contribution to live birth rate in BC from April 2008 to March 2018, which has not been addressed in the literature as of yet. Not only will it give healthcare providers and patients information about this emerging approach to infertility but also provide a impetus for healthy policy makers to adopt a model for partially or fully publicly funded ART, as seen in Ontario and soon Quebec.

Conditions

  • Assisted Reproductive Techniques

Interventions

PROCEDURE

Assisted Reproductive Technology

Assisted reproductive technology includes IVF and IVF+ICSI.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Mohamed Bedaiwy, MD, PhD · University of British Columbia

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2018-03-31
Completion
2018-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04373239 on ClinicalTrials.gov